May 06, 2021 / 12:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the BioCryst First Quarter 2021 Earnings Call. Please note that today's call is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker for today, John Bluth at BioCryst. John, the floor is yours.
John D. Bluth - BioCryst Pharmaceuticals, Inc. - SVP of IR & Corporate Communications
Thanks, Jay. Good morning and welcome to BioCryst's First Quarter 2021 Corporate Update and Financial Results Conference Call. Today's press release is available on our website. Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Commercial Officer, Charlie Gayer; Chief Medical Officer, Dr. Bill Sheridan; Chief Business Officer, Megan Sniecinski; and Chief R&D Officer, Dr. Helen Thackray. Following our remarks, we will answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking
Q1 2021 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot